Boston Common Asset Management LLC Lowers Stock Position in Danaher Corporation $DHR

Boston Common Asset Management LLC lowered its stake in shares of Danaher Corporation (NYSE:DHR) by 3.3% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 87,844 shares of the conglomerate’s stock after selling 2,973 shares during the quarter. Boston Common Asset Management LLC’s holdings in Danaher were worth $17,353,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. grew its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after buying an additional 99 shares during the period. Sierra Ocean LLC grew its position in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in Danaher during the first quarter valued at about $31,000. Dunhill Financial LLC grew its position in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after buying an additional 67 shares during the period. Finally, Costello Asset Management INC bought a new position in Danaher during the first quarter valued at about $41,000. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on DHR. Evercore ISI lowered their price target on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 8th. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research note on Tuesday, September 2nd. Wells Fargo & Company dropped their price target on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 23rd. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a research note on Saturday, September 27th. Finally, UBS Group dropped their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $245.91.

Insider Activity at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Trading Up 2.2%

Shares of Danaher stock opened at $215.05 on Friday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.41. The firm has a market cap of $153.98 billion, a PE ratio of 45.75, a PEG ratio of 3.06 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The company has a 50 day simple moving average of $200.19 and a two-hundred day simple moving average of $197.33.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same period in the previous year, the business posted $1.72 earnings per share. Danaher’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.